Search

everythinglearnresearchcommunity

for

Search:↓

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Pantethine may boost the immune system's ability to fight sarcoma.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

CD98hc's role in skin health decreases with age.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

5-Aminolevulinic acid can help chicken sperm move better at the right amount.

Finasteride helps reduce priapism in sickle cell anemia patients.

Vesicles from irradiated mouse cheek skin help cells survive radiation.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Garlic may help reduce side effects of breast cancer treatments.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Vitamin C was found to effectively treat prickly heat in children.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.